Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr Mohaghegh Biotechnology Research Center (DMBRC) is a private biotechnology organization based in Tehran, Iran, dedicated to the advancement of microbial technologies and enzyme production. The center specializes in the isolation, identification, and commercialization of probiotic strains for human and animal health applications. DMBRC offers a range of commercial products, including dietary supplements designed to modulate the gut microbiota and improve gastrointestinal health. In addition to its health-focused portfolio, the center produces high-quality industrial enzymes for the food and textile sectors. By leveraging expertise in fermentation and molecular biology, the research center provides comprehensive R&D services and laboratory testing for the regional biotech industry. The organization is particularly noted for its work in developing indigenous microbial solutions tailored to the Middle Eastern market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Mohaghegh Biotechnology Research Center.